Population Pharmacokinetics of Tofacitinib in De Novo Kidney Transplant Patients.

被引：0
|
作者：
Tortorici, M. [1 ]
Lamba, M. [1 ]
Chan, G. [1 ]
Krishnaswami, S. [1 ]
机构：
[1] Pfizer Inc, Groton, CT 06340 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：335 / 335
页数：1
相关论文
共 50 条
  • [1] Everolimus clinical pharmacokinetics in pediatric de novo kidney transplant patients.
    Kovarik, JM
    Hoyer, PF
    Ettenger, R
    Moeller, V
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 207 - 207
  • [2] Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in de Novo Pediatric Kidney Transplant Recipients
    Zhao, Wei
    Elie, Valery
    Roussey, Gwenaelle
    Brochard, Karine
    Niaudet, Patrick
    Deschenes, Georges
    Cochat, Pierre
    Cloarec, Sylvie
    Andre, Jean Luc
    Tsimaratos, Michel
    Bensman, Albert
    Fakhoury, May
    Jacqz-Aigrain, Evelyne
    THERAPEUTIC DRUG MONITORING, 2009, 31 (05) : 662 - 662
  • [3] Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients
    Zhao, W.
    Elie, V.
    Roussey, G.
    Brochard, K.
    Niaudet, P.
    Leroy, V.
    Loirat, C.
    Cochat, P.
    Cloarec, S.
    Andre, J. L.
    Garaix, F.
    Bensman, A.
    Fakhoury, M.
    Jacqz-Aigrain, E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (06) : 609 - 618
  • [4] POPULATION PHARMACOKINETICS AND PHARMACOGENETICS OF TACROLIMUS IN DE NOVO PAEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
    Zhao, W.
    Elie, V
    Roussey, G.
    Brochard, K.
    Niaudet, P.
    Deschenes, G.
    Cochat, P.
    Cloarec, S.
    Andre, J. L.
    Tsimaratos, M.
    Bensman, A.
    Fakhoury, M.
    Jacqz-Aigrain, E.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 37 - 38
  • [5] Pharmacodynamics and immunogenicity of basiliximab (Simulect) in pediatric de novo kidney transplant patients.
    Kovarik, JM
    Gerbeau, C
    Chodoff, L
    Hall, M
    TRANSPLANTATION, 2000, 69 (08) : S260 - S260
  • [6] Population pharmacokinetics of sirolimus in de novo Chinese adult renal transplant patients
    Jiao, Zheng
    Shi, Xiao-jin
    Li, Zhong-dong
    Zhong, Ming-kang
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (01) : 47 - 60
  • [7] Tacrolimus Pharmacokinetics When Combined with the Protein Kinase C Inhibitor AEB071 in De Novo Kidney Transplant Patients.
    Kovarik, J. M.
    Steiger, J. U.
    Grinyo, J. M.
    Rostaing, L.
    Arns, W.
    Dantal, J.
    Slade, A.
    Barten, M. J.
    Budde, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 323 - 323
  • [8] Therapeutic equivalence and pharmacokinetics of generic tacrolimus formulation in de novo kidney transplant patients
    Min, Sang-Il
    Ha, Jongwon
    Kim, Yon Su
    Ahn, Sang Hyun
    Park, Taejin
    Do Park, Dae
    Kim, Suh Min
    Min, Seung-Kee
    Hong, Hyejin
    Ahn, Curie
    Kim, Sang Joon
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (12) : 3110 - 3119
  • [9] Longitudinal assessment of the steady-state pharmacokinetics of RAD in de novo renal transplant patients.
    Kovarik, JM
    Rordorf, C
    Kahan, BD
    Kaplan, B
    Lorber, M
    Winkler, M
    Cambon, N
    Rouilly, M
    Boger, R
    TRANSPLANTATION, 2000, 69 (08) : S154 - S154
  • [10] Population pharmacokinetics of everolimus in de novo renal transplant patients: Impact of ethnicity and comedications
    Kovarik, JM
    Hsu, CH
    McMahon, L
    Berthier, S
    Rordorf, C
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (03) : 247 - 254
12345